[1] Oh YJ, Seo YH.A novel chalcone-based molecule, BDP inhibits MDA-MB-231 triple-negative breast cancer cell growth by suppressing Hsp90 function[J]. Oncol Rep, 2017, 38(4): 2343-2350. [2] Massimini M, Palmieri C, De Maria R, et al.17-AAG and Apoptosis, Autophagy, and Mitophagy in Canine Osteosarcoma Cell Lines[J].Vet Pathol, 2017, 54(3): 405-412. [3] Weber H, Valbuena JR, Barbhuiya MA, et al.Small molecule inhibitor screening identified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer[J]. Oncotarget, 2017, 8(16): 26169-26184. [4] Woo JK, Jang JE, Kang JH, et al.Lectin, Galactoside-Binding Soluble 3 Binding Protein Promotes 17-N- Allylamino-17-demethoxygeldanamycin Resistance through PI3K/Akt Pathway in Lung Cancer Cell Line[J]. Mol Cancer Ther, 2017, 16(7): 1355-1365. [5] Raja SM, Clubb RJ, Bhattacharyya M, et al.A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2- overexpressing breast cancer cells[J]. Cancer Biol Ther, 2008, 7(10): 1630-1640. [6] Lubbe WJ, Zhou ZY, Fu W, et al.Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer[J]. Clin Cancer Res, 2006, 12(6): 1876-1882. [7] Qin H, Liu X, Li F, et al.PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling[J]. Cancer Lett, 2017, 409: 30-41. [8] Liu WL, Chang JM, Chong IW, et al. Curcumin Inhibits LIN-28A through the Activation of miRNA-98 in the Lung Cancer Cell Line A549[J]. Molecules, 2017, 22(6). pii: E929. [9] Cheng TC, Din ZH, Su JH, et al. Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase -2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells[J]. Mar Drugs, 2017, 15(8). pii: E238. [10] Im I, Park KR, Kim SM,et al.The butanol fraction of guava (Psidium cattleianum Sabine) leaf extract suppresses MMP-2 and MMP-9 expression and activity through the suppression of the ERK1/2 MAPK signaling pathway[J]. Nutr Cancer, 2012, 64(2): 255-266. |